Comparative Study of Intestinal Color Ultrasound and Capsule Endoscopy in Monitoring Crohn's Disease
Launched by NANFANG HOSPITAL, SOUTHERN MEDICAL UNIVERSITY · Dec 1, 2022
Trial Information
Current as of January 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The disease activity index under intestinal color ultrasound was evaluated by SUS-CD, and the disease activity index under capsule endoscopy was evaluated by CECDAI. Active lesions under intestinal color ultrasound were defined as SUS-CD ≥ 1, and active lesions under capsule endoscopy were defined as CECDAI ≥ 3.9. All subjects underwent intestinal color ultrasound and capsule endoscopy at baseline and 3 months after treatment. To compare the correlation between SUS-CD and CECDAI before and after treatment, and to compare the role of intestinal color ultrasound and capsule endoscopy in monit...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1.Patients diagnosed with Crohn's disease according to the 2019 European Guidelines for Crohn's disease;
- • 2.At the time of inclusion, there were active lesions under color ultrasound or capsule endoscopy;
- • 3.Voluntarily sign an informed consent form.
- Exclusion Criteria:
- • 1.Patients with contraindications for capsule endoscopy;
- • 2.In the judgment of the investigator, it is not suitable to participate in this study.
Trial Officials
Xinmei Zhao, doctor
Study Chair
Nanfang Hospital, Southern Medical University
About Nanfang Hospital, Southern Medical University
Nanfang Hospital, affiliated with Southern Medical University, is a leading medical institution in China renowned for its comprehensive clinical services and commitment to advancing healthcare through research and education. As a clinical trial sponsor, Nanfang Hospital leverages its state-of-the-art facilities and a multidisciplinary team of expert researchers to conduct innovative studies aimed at improving patient outcomes and contributing to the global medical community. The hospital's focus on ethical standards and patient safety ensures that all trials are conducted with the highest level of integrity and scientific rigor.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guangzhou, Guangdong, China
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials